• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血清标本混合检测丙型肝炎病毒抗体筛查可行性的血清流行病学研究]

[Seroepidemiologic study on the feasibility of screening for the antibody to HCV by pooling the serum specimens].

作者信息

Liu P, Shu H, Zhang Y

机构信息

Department of Hygiene, Xuzhou Medical College.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 1994 Jun;15(3):179-81.

PMID:7530601
Abstract

The feasibility of screening for the antibody to HCV by pooling 10 serum specimens was studied by utilizing the epidemiologic method of single blind random allocation. We changed only the ratio between the pooled serum specimen volume and the serum specimen diluent volume, with their total volume and single serum specimen volume being as much as the volume required by EIA. Other steps were the same as those of EIA. The result showed that taking single serum specimen as the control group, the sensitivity and specificity of pooled serum specimen were 100% and 97.6%, respectively. The false positive rate was 2.4%, Kappa value was 0.95 (P < 0.05). The analysis of profit found that remarkable social and economic benefit will be obtained when serum pooling method is used. These results demonstrate that pooling 10 serum specimens is feasible to screening the antibody to HCV in blood donors by EIA.

摘要

采用单盲随机分配的流行病学方法,研究了将10份血清标本混合用于丙型肝炎病毒(HCV)抗体筛查的可行性。我们仅改变了混合血清标本体积与血清标本稀释液体积之间的比例,其总体积和单份血清标本体积与酶免疫分析(EIA)所需体积相同。其他步骤与EIA相同。结果显示,以单份血清标本作为对照组,混合血清标本的敏感性和特异性分别为100%和97.6%。假阳性率为2.4%,Kappa值为0.95(P<0.05)。效益分析发现,采用血清混合法将获得显著的社会和经济效益。这些结果表明,将10份血清标本混合用于通过EIA筛查献血者的HCV抗体是可行的。

相似文献

1
[Seroepidemiologic study on the feasibility of screening for the antibody to HCV by pooling the serum specimens].[血清标本混合检测丙型肝炎病毒抗体筛查可行性的血清流行病学研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 1994 Jun;15(3):179-81.
2
Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.台湾志愿献血者中的丙型肝炎病毒感染。通过丙型肝炎抗体检测和聚合酶链反应进行评估。
Arch Pathol Lab Med. 1993 Feb;117(2):152-6.
3
Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.抗丙型肝炎病毒酶免疫测定的信号与临界值比值在中国献血者筛查中的意义
Transfusion. 2005 Nov;45(11):1816-22. doi: 10.1111/j.1537-2995.2005.00611.x.
4
Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.乌干达献血者中丙型肝炎病毒的流行率及筛查成本
Trop Med Int Health. 2006 Jun;11(6):951-4. doi: 10.1111/j.1365-3156.2006.01643.x.
5
Association of HCV and Treponema pallidum infection in HIV infected northeastern Thai male blood donors.泰国东北部感染人类免疫缺陷病毒的男性献血者中丙型肝炎病毒与梅毒螺旋体感染的关联
J Med Assoc Thai. 1997 Sep;80 Suppl 1:S106-11.
6
[A seroepidemiological investigation on HCV infection among population in Tianjin area].[天津地区人群丙型肝炎病毒感染的血清流行病学调查]
Zhonghua Liu Xing Bing Xue Za Zhi. 1993 Jun;14(3):147-50.
7
[HCV-positive blood donors. Risk factors].[丙型肝炎病毒阳性献血者。风险因素]
Rev Esp Enferm Dig. 1995 Feb;87(2):179-80.
8
Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.评估一种用于对献血者进行常规抗丙型肝炎病毒筛查的混合检测方法,以减轻发展中国家血库的成本负担。
J Med Virol. 1996 Jul;49(3):218-22. doi: 10.1002/(SICI)1096-9071(199607)49:3<218::AID-JMV10>3.0.CO;2-8.
9
Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.塞舌尔普通人群中乙肝患病率下降,丙肝病毒感染率较低。
Bull World Health Organ. 1999;77(11):923-8.
10
Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.通过病史和自我排除表格评估的合格与延期献血者候选人中的丙型肝炎血清流行率。
Transfusion. 2004 Sep;44(9):1344-9. doi: 10.1111/j.1537-2995.2004.03379.x.